Estrogen Contributes to Gender Differences in Mouse Ventricular Repolarization
Overview
Authors
Affiliations
Rationale: Fast-transient outward K(+) (I(to,f)) and ultrarapid delayed rectifier K(+) currents (I(K,slow), also known as I(Kur)) contribute to mouse cardiac repolarization. Gender studies on these currents have reported conflicting results.
Objective: Key missing information in these studies is the estral stage of the animals. We revisited gender-related differences in K(+) currents, taking into consideration the females' estral stage. We hypothesized that changes in estrogen levels during the estral cycle could play a role in determining the densities of K(+) currents underlying ventricular repolarization.
Methods And Results: Peak total K(+) current (I(K,total)) densities (pA/pF, at +40 mV) were much higher in males (48.6+/-3.0) versus females at estrus (27.2+/-2.3) but not at diestrus-2 (39.1+/-3.4). Underlying this change, I(to,f) and I(K,slow) were lower in females at estrus versus males and diestrus-2 (I(K,slow): male 21.9+/-1.8, estrus 14.6+/-0.6, diestrus-2 20.3+/-1.4; I(to,f): male 26.8+/-1.9, estrus 14.9+/-1.6, diestrus-2 22.1+/-2.1). Lower I(K,slow) in estrus was attributable to only I(K,slow)(1) reduction, without changes in I(K,slow)(2). Estrogen treatment of ovariectomized mice decreased I(K,total) (46.4+/-3.0 to 28.4+/-1.6), I(to,f) (26.6+/-1.6 to 12.8+/-1.0) and I(K,slow) (22.2+/-1.6 to 17.2+/-1.4). Transcript levels of Kv4.3 and Kv1.5 (underlying I(to,f) and I(K,slow), respectively) were lower in estrus versus diestrus-2 and male. In ovariectomized mice, estrogen treatment resulted in downregulation of Kv4.3 and Kv1.5 but not Kv4.2, KChIP2, or Kv2.1 transcripts. K(+) current reduction in high estrogenic conditions were associated with prolongation of the action potential duration and corrected QT interval.
Conclusion: Downregulation of Kv4.3 and Kv1.5 transcripts by estrogen are one mechanism defining gender-related differences in mouse ventricular repolarization.
Dargam V, Sanchez A, Kolengaden A, Perez Y, Arias R, Valentin Cabrera A J Cardiovasc Dev Dis. 2024; 11(11).
PMID: 39590205 PMC: 11594452. DOI: 10.3390/jcdd11110362.
Chen K, Kenney H, Schwarz E, Rahimi H J Endocr Soc. 2024; 8(11):bvae169.
PMID: 39416428 PMC: 11481022. DOI: 10.1210/jendso/bvae169.
Zhang X, Wu Y, Smith C, Louch W, Morotti S, Dobrev D JACC Clin Electrophysiol. 2024; 10(11):2371-2391.
PMID: 39340505 PMC: 11602355. DOI: 10.1016/j.jacep.2024.07.020.
Luo Y, Safabakhsh S, Palumbo A, Fiset C, Shen C, Parker J Int J Mol Sci. 2024; 25(11).
PMID: 38892161 PMC: 11172775. DOI: 10.3390/ijms25115964.
Atrial fibrillation de novo in acute coronary syndrome.
Trujillo-Flores D, Garcia-Mendoza J Arch Cardiol Mex. 2024; 94(2):181-190.
PMID: 38648718 PMC: 11160543. DOI: 10.24875/ACM.23000008.